查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2056455

登革熱檢測市場報告：按檢測類型、最終用戶和地區分類（2026-2034 年）

Dengue Testing Market Report by Test Type (ELISA-based Tests, RT-PCR based Tests, Dengue IgG/IgM Rapid Test, and Others), End User (Hospitals, Diagnostic Centers, and Others), and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 147 Pages | 商品交期: 2-3個工作天內

價格

2025年全球登革熱檢測市場規模達6.372億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到9.292億美元，2026年至2034年的複合年成長率為4.15%。推動該市場成長的主要因素包括登革熱在全球的蔓延、診斷技術的進步、公眾健康意識的提高以及世界各地流行地區政府的舉措和資金投入。

登革熱（也稱為骨折熱）是一種病毒性疾病，透過受感染的埃及斑蚊叮咬傳播。它會導致關節和肌肉疼痛、高燒、腹痛、嘔吐、呼吸困難、皮膚冰冷潮濕、頭痛、眼球後疼痛、疲勞、皮疹以及輕微的鼻出血和牙齦出血。診斷包括登革熱檢測，例如酵素免疫分析法(ELISA)、逆轉錄聚合酶鍊式反應 (RT-PCR) 和快速登革熱 IgG/IgM 抗體檢測。醫護人員使用血液樣本進行登革熱檢測，以識別登革病毒的不同血清型。

登革熱檢測市場趨勢：

由於全球暖化加劇和蚊蟲滋生地在全球擴張，登革熱病例數量不斷增加，這是推動市場成長的主要因素之一。此外，準確且高效的登革熱診斷在臨床診療中發揮著至關重要的作用。這有助於闡明病因、進行臨床試驗、控制集體爆發、進行學術研究、研發疫苗、進行監測活動、早期發現重症病例以及確診病例並與其他感染疾病進行鑑別診斷。這些優勢正正面影響著全球對登革熱檢測的需求。此外，由於生活條件惡劣，世界各地人口稠密的地區更容易受到感染疾病。而且，由於公眾意識不足，衛生設施和廢棄物處理技術不完善，也促進了市場成長。此外，醫療專業人員建議透過熱噴灑殺蟲劑進行自我防護和預防登革熱。這與各國政府進行的宣傳宣傳活動結合，正在推動市場成長。其他成長要素還包括快速的都市化和醫療產業的科技進步。此外，主要市場參與者正大力投資研發活動，以開發高效且經濟的登革熱檢測套組。

市場區隔:

本報告分析了全球登革熱檢測市場各細分領域的關鍵趨勢，並對2026年至2034年全球、區域和國家特定市場進行了預測。報告根據檢測類型和最終用戶對市場進行了分類。

按測試類型細分：

  • 基於酵素連結免疫吸附試驗（ELISA）的檢測
  • 基於RT-PCR的檢測
  • 登革熱IgG/IgM快速檢測
  • 其他

按最終用戶細分：

  • 醫院
  • 診斷中心
  • 其他

按地區分類：

  • 北美洲
  • 我們
  • 加拿大
  • 亞太地區
  • 中國
  • 日本
  • 印度
  • 韓國
  • 澳洲
  • 印尼
  • 其他
  • 歐洲
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙
  • 俄羅斯
  • 其他
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 其他
  • 中東和非洲

競爭格局：

也調查了該行業的競爭格局，主要公司簡介包括 Abbott Laboratories、Abnova Corporation、Celltest Biotech SL、Diasolin SpA、F. Hoffmann-La Roche AG、Inbios International、Novatek Immun Diagnostics GmbH、Origin Technologies、PerkinElmer、Quest Diagnostics 和 Themo Fisher 地區。

本報告解答的主要問題

1. 登革熱檢測市場規模有多大？

2. 2026 年至 2034 年全球登革熱檢測市場的預期成長率為何？

3. 推動全球登革熱檢測市場發展的主要因素是什麼？

4. COVID-19 對全球登革熱檢測市場產生了哪些影響？

5. 從檢測類型來看，全球登革熱檢測市場是如何分類的？

6. 全球登革熱檢測市場按最終用戶分類的組成是什麼？

7. 全球登革熱檢測市場的主要地區有哪些？

8. 全球登革熱檢測市場的主要參與者/公司有哪些？

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 二手資訊
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球登革熱檢測市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依測試類型分類

  • 基於ELISA方法的檢測
  • 基於RT-PCR的檢測
  • 登革熱IgG/IgM快速檢測
  • 其他

第7章 市場區隔：依最終用戶分類

  • 醫院
  • 診斷中心
  • 其他

第8章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第9章 SWOT 分析

第10章：價值鏈分析

第11章：波特五力分析

第12章：價格分析

第13章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Abbott Laboratories
    • Abnova Corporation
    • CerTest Biotec SL
    • DiaSorin SpA
    • F. Hoffmann-La Roche AG
    • InBios International Inc.
    • NovaTec Immundiagnostica GmbH
    • OriGene Technologies Inc.
    • PerkinElmer Inc.
    • Quest Diagnostics Incorporated
    • Thermo Fisher Scientific Inc.
Product Code: SR112026A5648

The global dengue testing market size reached USD 637.2 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 929.2 Million by 2034, exhibiting a growth rate (CAGR) of 4.15% during 2026-2034. The market is primarily driven by the increasing dengue fever prevalence worldwide, advancements in diagnostic technologies, rising public health awareness, and government initiatives and funding in endemic regions across the globe.

Dengue, also known as breakbone fever, is a viral infection that spreads through the bite of an infected Aedes aegypti mosquito. It causes ache in the joints and muscles, high fever, abdominal pain, vomiting, difficulty in breathing, clammy and cold skin, headache, pain behind the eyes, fatigue, rashes, and mild bleeding in the nose and gums. It is diagnosed via dengue testing, which includes enzyme-linked immunosorbent assay (ELISA), RT-PCR, and dengue IgG/IgM rapid tests. Dengue testing is performed by medical professionals using a blood sample to identify the different serotypes of the dengue virus.

Dengue Testing Market Trends:

The growing cases of dengue on account of the rising global warming and breeding sites of mosquitos across the globe represents one of the major factors driving the market. Moreover, accurate and efficient diagnosis of dengue plays a pivotal role in clinical care. It assists in pathogenesis, clinical trials, outbreak control, academic research, vaccine development, surveillance activities, early detection of severe cases, and case confirmation and differential diagnosis with other infectious diseases. These benefits are positively influencing the demand for dengue testing around the world. Besides this, densely populated areas worldwide are more disease-prone due to low living conditions. This, along with poor sanitation and waste management techniques due to lack of public awareness, is stimulating the growth of the market. In addition, healthcare professionals are encouraging people to prevent dengue by self-protection and thermal fogging of insecticides. This, coupled with awareness campaigns organized by the government of several countries, is propelling the growth of the market. Other growth-inducing factors are rapid urbanization and technological advancements in the healthcare industry. Furthermore, key market players are extensively investing in research and development (R&D) activities to develop highly efficient and cost-effective dengue test kits.

Market Segmentation:

This report provides an analysis of the key trends in each sub-segment of the global dengue testing market report, along with forecasts at the global, regional and country levels from 2026-2034. The report categorizes the market based on test type and end user.

Breakup by Test Type:

  • ELISA-based Tests
  • RT-PCR based Tests
  • Dengue IgG/IgM Rapid Test
  • Others

Breakup by End User:

  • Hospitals
  • Diagnostic Centers
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Abnova Corporation, CerTest Biotec S.L., DiaSorin S.p.A., F. Hoffmann-La Roche AG, InBios International Inc., NovaTec Immundiagnostica GmbH, OriGene Technologies Inc., PerkinElmer Inc., Quest Diagnostics Incorporated and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

1. How big is the dengue testing market?

2. What is the expected growth rate of the global dengue testing market during 2026-2034?

3. What are the key factors driving the global dengue testing market?

4. What has been the impact of COVID-19 on the global dengue testing market?

5. What is the breakup of the global dengue testing market based on the test type?

6. What is the breakup of the global dengue testing market based on the end user?

7. What are the key regions in the global dengue testing market?

8. Who are the key players/companies in the global dengue testing market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Dengue Testing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Test Type

  • 6.1 ELISA-based Tests
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 RT-PCR based Tests
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Dengue IgG/IgM Rapid Test
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by End User

  • 7.1 Hospitals
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Diagnostic Centers
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Abbott Laboratories
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Abnova Corporation
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
    • 13.3.3 CerTest Biotec S.L.
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
    • 13.3.4 DiaSorin S.p.A.
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 F. Hoffmann-La Roche AG
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
    • 13.3.6 InBios International Inc.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
    • 13.3.7 NovaTec Immundiagnostica GmbH
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
    • 13.3.8 OriGene Technologies Inc.
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
    • 13.3.9 PerkinElmer Inc.
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
      • 13.3.9.4 SWOT Analysis
    • 13.3.10 Quest Diagnostics Incorporated
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis
    • 13.3.11 Thermo Fisher Scientific Inc.
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio
      • 13.3.11.3 Financials
      • 13.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Dengue Testing Market: Major Drivers and Challenges
  • Figure 2: Global: Dengue Testing Market: Sales Value (in Million USD), 2020-2025
  • Figure 3: Global: Dengue Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 4: Global: Dengue Testing Market: Breakup by Test Type (in %), 2025
  • Figure 5: Global: Dengue Testing Market: Breakup by End User (in %), 2025
  • Figure 6: Global: Dengue Testing Market: Breakup by Region (in %), 2025
  • Figure 7: Global: Dengue Testing (ELISA-based Tests) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 8: Global: Dengue Testing (ELISA-based Tests) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 9: Global: Dengue Testing (RT-PCR based Tests) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Dengue Testing (RT-PCR based Tests) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Dengue Testing (Dengue IgG/IgM Rapid Test) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Dengue Testing (Dengue IgG/IgM Rapid Test) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Dengue Testing (Other Test Types) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Dengue Testing (Other Test Types) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Dengue Testing (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Dengue Testing (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Dengue Testing (Diagnostic Centers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Dengue Testing (Diagnostic Centers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Dengue Testing (Other End Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Dengue Testing (Other End Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: North America: Dengue Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: North America: Dengue Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: United States: Dengue Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: United States: Dengue Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Canada: Dengue Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Canada: Dengue Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Asia-Pacific: Dengue Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Asia-Pacific: Dengue Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: China: Dengue Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: China: Dengue Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: Japan: Dengue Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: Japan: Dengue Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: India: Dengue Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: India: Dengue Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: South Korea: Dengue Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: South Korea: Dengue Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: Australia: Dengue Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: Australia: Dengue Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: Indonesia: Dengue Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: Indonesia: Dengue Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: Others: Dengue Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: Others: Dengue Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: Europe: Dengue Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: Europe: Dengue Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: Germany: Dengue Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: Germany: Dengue Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: France: Dengue Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: France: Dengue Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: United Kingdom: Dengue Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: United Kingdom: Dengue Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: Italy: Dengue Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: Italy: Dengue Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: Spain: Dengue Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: Spain: Dengue Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: Russia: Dengue Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: Russia: Dengue Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: Others: Dengue Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: Others: Dengue Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: Latin America: Dengue Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: Latin America: Dengue Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: Brazil: Dengue Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: Brazil: Dengue Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: Mexico: Dengue Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: Mexico: Dengue Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: Others: Dengue Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: Others: Dengue Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: Middle East and Africa: Dengue Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: Middle East and Africa: Dengue Testing Market: Breakup by Country (in %), 2025
  • Figure 69: Middle East and Africa: Dengue Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Global: Dengue Testing Industry: SWOT Analysis
  • Figure 71: Global: Dengue Testing Industry: Value Chain Analysis
  • Figure 72: Global: Dengue Testing Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Dengue Testing Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Dengue Testing Market Forecast: Breakup by Test Type (in Million USD), 2026-2034
  • Table 3: Global: Dengue Testing Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 4: Global: Dengue Testing Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 5: Global: Dengue Testing Market: Competitive Structure
  • Table 6: Global: Dengue Testing Market: Key Players